CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Malignant lymph nodesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05754814
NCT05754814N/ACompleted
CompareCT.gov

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

Rigshospitalet, Denmark·observational·Posted Mar 6, 2023·Updated May 8, 2026

In Brief

An observational study evaluating Malignant lymph nodes for Head and Neck Cancer and 2 related conditions. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The goal of this observational study is to visualize the small vessels in normal and cancerous lymph nodes on the neck with a new ultrasound technique. The main questions it aims to answer are: * Is it possible to visualize the network of the smallest vessels in lymph nodes on the neck? * Is it possible to distinguish between healthy and cancerous lymph nodes using different parameters? The participants will have 1 lymph nodes ultrasound scanned with a standard ultrasound technique and the new technique.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer, Lymphoma, Lymph Node Metastasis
CountriesDenmark
CollaboratorsTechnical University of Denmark, University of Copenhagen

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 6, 2023
Enrollment StartJun 28, 2022
Primary CompletionApr 1, 2026
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 3.3 years ago

Interventions

Malignant lymph nodesother

Patients with a condition; either lymphoma on the neck or head and neck cancer with lymph node metastases on the neck.